1998
DOI: 10.1016/s0959-8049(98)00148-8
|View full text |Cite
|
Sign up to set email alerts
|

Advance directives and other medical decisions concerning the end of life in cancer patients in Japan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
48
0
1

Year Published

2001
2001
2013
2013

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 45 publications
(51 citation statements)
references
References 14 publications
2
48
0
1
Order By: Relevance
“…However, a medical dilemma that begins to emerge more often, today, is the benefit of cardio-respiratory resuscitation of patients with incurable diseases, especially in the final stage. Medical deontology plays a significant role because it includes the basic rules of behaviour from which doctors will be inspired and they need to follow these rules in a legal and social frame [24] .…”
Section: Medical Opinionsmentioning
confidence: 99%
“…However, a medical dilemma that begins to emerge more often, today, is the benefit of cardio-respiratory resuscitation of patients with incurable diseases, especially in the final stage. Medical deontology plays a significant role because it includes the basic rules of behaviour from which doctors will be inspired and they need to follow these rules in a legal and social frame [24] .…”
Section: Medical Opinionsmentioning
confidence: 99%
“…Previous studies investigated some aspects of quality of end-of-life care in Japan as follows: satisfaction of end-of-life care for cancer patients who died in PCUs [18], the efficacy of PCTs [19,20], documentation of DNR orders in a teaching hospital [21], treatments and status of disclosure in the last 48 h of life in PCU and those provided in a geriatric hospital, where 42% of patients had cancer [22]. It is unclear who actually consents to DNR; however, in Japan, a cultural feature is that the family plays a greater role in this type of decision making [23][24][25]. There is also limited information about the comprehensive aspects of end-of-life treatment provided for dying cancer patients in general wards, and there are no data regarding QIs because of underdeveloped cancer registries in Japan.…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, our findings may be subject to recall bias. However, bias from surrogate respondents can be justified because end-oflife decision-making is more often entrusted to families rather than to patients in Japan [29][30][31]. Second, there was insufficient information regarding physical and psychological symptoms.…”
Section: Discussionmentioning
confidence: 99%